Product Code: GVR-4-68038-750-6
Ultrasound Gels Market Growth & Trends:
The global ultrasound gel market size is estimated to reach USD 124.0 million by 2030, registering a CAGR of 2.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The increasing adoption rate of ultrasound devices in healthcare settings due to its diagnostic efficiency and cost-effectiveness is the factor expected to drive the demand for the conductive medium during the forecast period. In addition, the increasing number of external sonography procedures requiring a low level of sterility has contributed to its largest market share.
Increasing patient visits reporting problems such as heart disease, kidney and gallbladder problems, and lung and intestinal diseases where ultrasound primarily finds application is expected to increase the consumption rate of the gel. Growing concern to protect the ultrasound transducer from damages and the developing trend to provide utmost patient satisfaction during treatment has led to increasing demand for odorless, colorless, and stain-free ultrasound gels. The availability of handheld sonography devices at affordable prices has promoted their adoption rate in small-sized clinics. Therefore, the growing installation rate of sonography units in clinics has contributed to the rising demand of gel in these setups.
Availability of alternative to ultrasound gels, the advent of gel-free sonography probes, and limited access to medical consumables in rural areas are expected to resist the growth of the market during the forecast period. The gel-free sonography probes can be a major threat to the market, but its expensiveness is limiting its adoption rate.
Ultrasound Gels Market Report Highlights:
- The non-sterile segment held the largest revenue share of 70.6% in 2022 and are expected to grow at a healthy CAGR over the forecast period
- The sterile segment is expected to experience the fastest growth rate during the forecast period
- The hospitals segment held the largest market share owing to its large patient pool, strict adherence to medical imaging protocols, and availability of advanced technology
- Ambulatory centers and clinics are anticipated to grow at the speediest rate during the forecast period
- North America dominated the market and accounted for the largest revenue share of 39.2% in 2022
- The increasing acceptance of sonography at community level clinics and home healthcare will drive the market growth in the region
- Asia Pacific is expected to be the fastest-growing region over the forecast period due to large unmet needs, increasing healthcare expenditure, and presence of several small-scale domestic manufacturers.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. End-use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. End-use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Ultrasound Gels Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.4. Ultrasound Gels Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic Landscape
Chapter 4. Ultrasound Gels: Type Estimates & Trend Analysis
- 4.1. Ultrasound Gels Market, By Type Key Takeaways
- 4.2. Ultrasound Gels Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Non-sterile
- 4.3.1. Non-sterile market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Sterile
- 4.4.1. Sterile market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Ultrasound Gels: End Use Estimates & Trend Analysis
- 5.1. Ultrasound Gels Market, By End Use Key Takeaways
- 5.2. Ultrasound Gels Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Hospitals
- 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Clinics
- 5.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Diagnostic Center
- 5.5.1. Diagnostic Center market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Ambulatory Center
- 5.6.1. Ambulatory Center market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Ultrasound Gels Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Ultrasound Gels Market by Region: Key Takeaways
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Denmark
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Norway
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. South Africa
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Compass Health Brands
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. ECO-MED
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. National Therapy Products
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. H.R Pharmaceuticals Inc
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Tele-Paper Malaysia
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Sonogel Vertriebs
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Medicine Industries, Inc
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Parker Laboratories
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Ultragel Kft.
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives